Part 10.2: Toxicology in ECC

Circulation

Volumn 112, Issue 24 SUPPL., 2005, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMPHETAMINE DERIVATIVE; ATENOLOL; CARBAMIC ACID DERIVATIVE; CARDIOVASCULAR AGENT; COCAINE; DESIPRAMINE; DIAMORPHINE; DIGITALIS; DIGITOXIN; DILTIAZEM; DIPHENHYDRAMINE; DOXYLAMINE; EPHEDRINE; FENTANYL; IMIPRAMINE; ISONIAZID; METHADONE; METOPROLOL; MORPHINE; NIFEDIPINE; NORTRIPTYLINE; OPIATE; ORGANOPHOSPHATE; PHENCYCLIDINE; PROCAINAMIDE; PROPRANOLOL; SOTALOL; UNINDEXED DRUG; VERAPAMIL;

ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; BRONCHOSPASM; CARDIOTOXICITY; CONFERENCE PAPER; HEART ARREST; HEART CATHETERIZATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOTENSION; HYPOVENTILATION; INTOXICATION; LUNG EDEMA; LUNG TOXICITY; MIOSIS; PRIORITY JOURNAL; SEIZURE; SHOCK; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA; TREATMENT INDICATION;

EID: 33744799453     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.166564     Document Type: Conference Paper

References (57)

1. Litovitz TL, Felberg L, White S, Klein-Schwartz W. 1995 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 1996;14:487-537.
2. McCaig LF, Burt CW. Poisoning-related visits to emergency departments in the United States, 1993-1996. J Toxicol Clin Toxicol. 1999;37:817-826.
3. Fingerhut LA, Cox CS. Poisoning mortality, 1985-1995. Public Health Rep. 1998;113:218-233.
4. Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, Youniss J, Reid N, Rouse WG, Rembert RS, Borys D. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2004;22:335-404.
5. Facility assessment guidelines for regional toxicology treatment centers. American Academy of Clinical Toxicology. J Toxicol Clin Toxicol. 1993;31:211-217.
6. Poison information and treatment systems. American College of Emergency Physicians. Ann Emerg Med. 1996;28:384.
7. Chyka PA, Seger D, Krenzelok EP, Vale JA. Position paper: single-dose activated charcoal. Clin Toxicol (Phila). 2005;43:61-87.
8. Amrein R, Hetzel W, Hartmann D, Lorscheid T. Clinical pharmacology of flumazenil. Eur J Anaesth. 1988;2:65-80.
9. Amrein R, Leishman B, Bentzinger C, et al. Flumazenil in benzodiazepine antagonism: actions and clinical use in intoxications and anaesthesiology. Med Toxicol. 1987;2:411-429.
10. Flückiger A, Hartmann D, Leishman B, et al. Lack of effect of the benzodiazepine antagonist flumazenil (Ro 15-1788) on the performance of healthy subjects during experimentally induced ethanol intoxication. Eur J Clin Pharmacol. 1988;34:273-276.
11. Lukes SE, Griffiths RR. Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro-15-1788) after 7 days of diazepam. Science. 1982;217:1161-1163.
12. Martens F, Köppel C, Ibe K, et al. Clinical experience with the benzodiazepine antagonist flumazenil in suspected benzodiazepine or ethanol poisoning. J Toxicol Clin Toxicol. 1990;28:341-356.
13. Pitetti RD, Singh S, Pierce MC. Safe and efficacious use of procedural sedation and analgesia by nonanesthesiologists in a pediatric emergency department. Arch Pediatr Adolesc Med. 2003;157:1090-1096.
14. Gill AM, Cousins A, Nunn AJ, Choonara JA. Opiate-induced respiratory depression in pediatric patients. Ann Pharmacother. 1996;30:125-129.
15. Herschel M, Kloshnood B, Lass NA. Role of naloxone in newborn resuscitation. Pediatrics. 2000;106:831-834.
16. Lewis JM, Klein-Schwartz W, Benson BE, Oderda GM, Takai S. Continuous naloxone infusion in pediatric narcotic overdose. Am J Dis Child. 1984;138:944-946.
17. Romac DR. Safety of prolonged, high-dose infusion of naloxone hydrochloride for severe methadone overdose. Clin Pharm. 1986;5:251-254.
18. Singhal N, McMillan DD, Yee WH, Akierman AR, Yee YJ. Evaluation of the effectiveness of the standardized neonatal resuscitation program. J Perinatol. 2001;21:388-392.
19. Osterwalder JJ. Naloxone - for intoxications with intravenous heroin and heroin mixtures - harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol. 1996;34:409-416.
20. Sporer KA, Firestone J, Isaacs SM. Out-of-hospital treatment of opioid overdoses in an urban setting. Acad Emerg Med. 1996;3:660-667.
21. Wanger K, Brough L, Macmillan I, Goulding J, MacPhail I, Christenson JM. Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose. Acad Emerg Med. 1998;5:293-299.
22. Hasan RA, Benko AS, Nolan BM, Campe J, Duff J, Zureikat GY. Cardiorespiratory effects of naloxone in children. Ann Pharmacother. 2003;37:1587-1592.
23. Sporer KA. Acute heroin overdose. Ann Intern Med. 1999;130:584-590.
24. Schneir AB, Vadeboncoeur TF, Offerman SR, Barry JD, Ly BT, Williams SR, Clark RF. Massive OxyContin ingestion refractory to naloxone therapy. Ann Emerg Med. 2002;40:425-428.
25. Sungur M, Guven M. Intensive care management of organophosphate insecticide poisoning. Crit Care. 2001;5:211-215.
26. Bosse GM, Pope TM. Recurrent digoxin overdose and treatment with digoxin-specific Fab antibody fragments. J Emerg Med. 1994;12:179-185.
27. Eddleston M, Rajapakse S, Rajakanthan, Jayalath S, Sjostrom L, Santharaj W, Thenabadu PN, Sheriff MH, Warrell DA. Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander: a randomised controlled trial. Lancet. 2000;355:967-972.
28. Dasgupta A, Szelei-Stevens KA. Neutralization of free digoxin-like immunoreactive components of oriental medicines Dan Shen and Lu-Shen-Wan by the Fab fragment of antidigoxin antibody (Digibind). Am J Clin Pathol. 2004;121:276-281.
29. Tracey JA, Cassidy N, Casey PB, Ali I. Bupropion (Zyban) toxicity. Ir Med J. 2002;95:23-24.
30. Burns MJ, Linden CH, Graudins A, Brown RM, Fletcher KE. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med. 2000;35:374-381.
31. Ramoska E, Sacchetti AD. Propranolol-induced hypertension in treatment of cocaine intoxication. Ann Emerg Med. 1985;14:1112-1113.
32. Hollander JE, Wilson LD, Shih LP. Complications from the use of thrombolytic agents in patients with cocaine associated chest pain. J Emerg Med. 1996;14:731-736.
33. Brogan WCI, Lange RA, Kim AS, Moliterno DJ, Hillis LD. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol. 1991;18:581-586.
34. Lange RA, Cigarroa RG, Yancy CW Jr, Willard JE, Popma JJ, Sills MN, McBride W, Kim AS, Hillis LD. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med. 1989;321:1557-1562.
35. Lange RA, Cigarroa RG, Flores ED, McBride W, Kim AS, Wells PJ, Bedotto JB, Danziger RS, Hillis LD. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med. 1990;112:897-903.
36. Boehrer JD, Moliterno DJ, Willard JE, Hillis LD, Lange RA. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med. 1993;94:608-610.
37. Gay GR, Loper KA. The use of labetalol in the management of cocaine crisis. Ann Emerg Med. 1988;17:282-283.
38. Dusenberry SJ, Hicks MJ, Mariani PJ. Labetalol treatment of cocaine toxicity. Ann Emerg Med. 1987;16:235.
39. Sand IC, Brody SL, Wrenn KD, Slovis CM. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am J Emerg Med. 1991;9:161-163.
40. Mayron R, Ruiz E. Phenytoin: does it reverse tricyclic-antidepressant- induced cardiac conduction abnormalities? Ann Emerg Med. 1986;15:876-880.
41. Callaham M, Schumaker H, Pentel P. Phenytoin prophylaxis of cardiotoxicity in experimental amitriptyline poisoning. J Pharmacol Exp Ther. 1988;245:216-220.
42. Citak A, Soysal DD, Ucsel R, Karabocuoglu M, Uzel N. Efficacy of long duration resuscitation and magnesium sulphate treatment in amitriptyline poisoning. Eur J Emerg Med. 2002;9:63-66.
43. Knudsen K, Abrahamsson J. Effects of magnesium sulfate and lidocaine in the treatment of ventricular arrhythmias in experimental amitriptyline poisoning in the rat. Crit Care Med. 1994;22:494-498.
44. Kline JA, DeStefano AA, Schroeder JD, Raymond RM. Magnesium potentiates imipramine toxicity in the isolated rat heart. Ann Emerg Med. 1994;24:224-232.
45. Gowda RM, Khan IA, Punukollu G, Vasavada BC, Sacchi TJ, Wilbur SL. Female preponderance in ibutilide-induced torsade de pointes. Int J Cardiol. 2004;95:219-222.
46. Brown TC. Sodium bicarbonate treatment for tricyclic antidepressant arrhythmias in children. Med J Aust. 1976;2:380-382.
47. Hoffman JR, Votey SR, Bayer M, Silver L. Effect of hypertonic sodium bicarbonate in the treatment of moderate-to-severe cyclic antidepressant overdose. Am J Emerg Med. 1993;11:336-341.
48. McKinney PE, Rasmussen R. Reversal of severe tricyclic antidepressant-induced cardiotoxicity with intravenous hypertonic saline solution. Ann Emerg Med. 2003;42:20-24.
49. Bailey PM, Little M, Jelinek GA, Wilce JA. Jellyfish envenoming syndromes: unknown toxic mechanisms and unproven therapies. Med J Aust. 2003;178:34-37.
50. Proano L, Chiang WK, Wang RY. Calcium channel blocker overdose. Am J Emerg Med. 1995;13:444-450.
51. Wenzel V, Lindner KH. Employing vasopressin during cardiopulmonary resuscitation and vasodilatory shock as a lifesaving vasopressor. Cardiovasc Res. 2001;51:529-541.
52. Ramsay ID. Survival after imipramine poisoning. Lancet. 1967;2:1308-1309.
53. Southall DP, Kilpatrick SM. Imipramine poisoning: survival of a child after prolonged cardiac massage. BMJ. 1974;4:508.
54. Kollef MH. Labetalol overdose successfully treated with amrinone and alpha-adrenergic receptor agonists. Chest. 1994;105:626-627.
55. Burkhart KK. Intravenous propranolol reverses hypertension after sympathomimetic overdose: two case reports. J Toxicol Clin Toxicol. 1992;30:109-114.
56. Durward A, Guerguerian AM, Lefebvre M, Shemie SD. Massive diltiazem overdose treated with extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2003;4:372-376.
57. Holzer M, Sterz F, Schoerkhuber W, et al. Successful resuscitation of a verapamil-intoxicated patient with percutaneous cardiopulmonary bypass. Crit Care Med. 1999;27:2818-2823.